{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T01:04:26Z","timestamp":1789261466401,"version":"build-2803163510"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jem-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Emergency Medicine"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.jemermed.2019.06.052","type":"journal-article","created":{"date-parts":[[2019,10,17]],"date-time":"2019-10-17T17:33:42Z","timestamp":1571333622000},"page":"e99-e104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Ibogaine Consumption With Seizure-Like Episodes, QTc-Prolongation, and Captured Cardiac Dysrhythmias"],"prefix":"10.1016","volume":"57","author":[{"given":"James","family":"Grogan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy","family":"Gerona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry W.","family":"Snow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jemermed.2019.06.052_bib1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1177\/0960327107087802","article-title":"Ibogaine, an anti-addictive drug: pharmacology and time to go further in development. A narrative review","volume":"27","author":"Maciulaitis","year":"2008","journal-title":"Hum Exp Toxicol"},{"key":"10.1016\/j.jemermed.2019.06.052_bib2","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1749-6632.1998.tb08237.x","article-title":"Mechanisms of antiaddictive actions of ibogainea","volume":"844","author":"Glick","year":"1988","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jemermed.2019.06.052_bib3","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1177\/0269881114552713","article-title":"Treating drug dependence with the aid of ibogaine: a retrospective study","volume":"28","author":"Schenberg","year":"2014","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.jemermed.2019.06.052_bib4","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/toxsci\/57.1.95","article-title":"A dose-response study of ibogaine-induced neuropathology in the rat cerebellum","volume":"57","author":"Xu","year":"2000","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.jemermed.2019.06.052_bib6","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/00952990.2017.1310218","article-title":"Ibogaine treatment outcomes for opioid dependence from a twelve-month follow-up observational study","volume":"44","author":"Noller","year":"2017","journal-title":"Am J Drug Alcohol Abuse"},{"key":"10.1016\/j.jemermed.2019.06.052_bib7","unstructured":"Guimar\u00e3es dos Santos R. Ibogaine in the treatment of alcoholism: a randomized, double-blind, placebo-controlled, escalating-dose, phase 2 trial. Available at: ClinicalTrials.gov\/ct2\/show\/NCT03380728. Accessed July 29, 2018."},{"key":"10.1016\/j.jemermed.2019.06.052_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2016.07.005","article-title":"Ibogaine for treating drug dependence. What is a safe dose?","volume":"166","author":"Schep","year":"2016","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.jemermed.2019.06.052_bib9","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2174\/1874473708666150107120011","article-title":"Psychedelics as medicines for substance abuse rehabilitation: evaluating treatments with LSD, peyote, ibogaine and ayahuasca","volume":"7","author":"Winkelman","year":"2015","journal-title":"Curr Drug Abuse Rev"},{"key":"10.1016\/j.jemermed.2019.06.052_bib10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jep.2007.08.034","article-title":"The ibogaine medical subculture","volume":"115","author":"Alper","year":"2008","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.jemermed.2019.06.052_bib11","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1556-4029.2011.02008.x","article-title":"Fatalities temporally associated with the ingestion of ibogaine","volume":"57","author":"Alper","year":"2012","journal-title":"J Forensic Sci"},{"key":"10.1016\/j.jemermed.2019.06.052_bib12","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/jcph.471","article-title":"Influence of CYP2D6 activity on the pharmacokinetics and pharmacodynamics of a single 20mg dose of ibogaine in healthy volunteers","volume":"55","author":"Glue","year":"2015","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.jemermed.2019.06.052_bib13","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1749-6632.2000.tb05213.x","article-title":"Ibogaine: complex pharmacokinetics, concerns for safety, and preliminary efficacy measures","volume":"914","author":"Mash","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jemermed.2019.06.052_bib14","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.ajem.2014.12.023","article-title":"Internet-purchased ibogaine toxicity confirmed with serum, urine, and product content levels","volume":"33","author":"O'Connell","year":"2015","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jemermed.2019.06.052_bib15","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1080\/15563650.2017.1287372","article-title":"Toxicokinetics of ibogaine and noribogaine in a patient with prolonged multiple cardiac arrhythmias after ingestion of internet purchased ibogaine","volume":"55","author":"Henstra","year":"2017","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.jemermed.2019.06.052_bib16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/15672050113109990001","article-title":"Ibogaine in the treatment of substance dependence","volume":"6","author":"Brown","year":"2013","journal-title":"Curr Drug Abuse Rev"},{"key":"10.1016\/j.jemermed.2019.06.052_bib17","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S0006-8993(97)00365-X","article-title":"Effects of chronic ibogaine treatment on cerebellar Purkinje cells in the rat","volume":"759","author":"Helsley","year":"1997","journal-title":"Brain Res"},{"key":"10.1016\/j.jemermed.2019.06.052_bib18","doi-asserted-by":"crossref","first-page":"642","DOI":"10.3109\/15563650.2014.927477","article-title":"Cardiac arrest after ibogaine ingestion","volume":"52","author":"Vlaanderen","year":"2014","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1016\/j.jemermed.2019.06.052_bib19","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1016\/j.jemermed.2015.06.051","article-title":"A case of QT prolongation and torsades de pointes caused by ibogaine toxicity","volume":"50","author":"Hildyard","year":"2016","journal-title":"J Emerg Med"},{"key":"10.1016\/j.jemermed.2019.06.052_bib20","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1093\/bja\/aet396","article-title":"Growing menace of ibogaine toxicity","volume":"111","author":"Asua","year":"2013","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jemermed.2019.06.052_bib21","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1056\/NEJMc0804248","article-title":"Long-QT syndrome induced by the antiaddiction drug ibogaine","volume":"360","author":"Hoelen","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jemermed.2019.06.052_bib22","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1080\/00952990.2017.1320802","article-title":"Treatment of opioid use disorder with ibogaine: detoxification and drug use outcomes","volume":"44","author":"Brown","year":"2017","journal-title":"Am J Drug Alcohol Abuse"},{"key":"10.1016\/j.jemermed.2019.06.052_bib23","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1369-1600.2012.00447.x","article-title":"Anti-addiction drug ibogaine inhibits HERG channels: a cardiac arrhythmia risk","volume":"19","author":"Koenig","year":"2012","journal-title":"Addict Biol"},{"key":"10.1016\/j.jemermed.2019.06.052_bib24","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1124\/jpet.113.209643","article-title":"Mechanism of HERG channel block by the psychoactive indole alkaloid ibogaine","volume":"348","author":"Thurner","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jemermed.2019.06.052_bib25","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3109\/15563650.2016.1138226","article-title":"How toxic is ibogaine?","volume":"54","author":"Litjens","year":"2016","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.jemermed.2019.06.052_bib26","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1080\/105504999305848","article-title":"Treatment of acute opioid withdrawal with ibogaine","volume":"8","author":"Alper","year":"1999","journal-title":"Am J Addict"},{"key":"10.1016\/j.jemermed.2019.06.052_bib27","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/scientificamerican1116-62","article-title":"Get clean or die trying","volume":"315","author":"Nestor","year":"2016","journal-title":"Sci Am"},{"key":"10.1016\/j.jemermed.2019.06.052_bib28","series-title":"Phase 2 trial to evaluate 18-methoxycoronaridine efficacy, safety and tolerability in cutaneous leishmaniasis patients","author":"Delorenzi","year":"2018"}],"container-title":["The Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0736467919305700?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0736467919305700?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:43:27Z","timestamp":1760028207000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0736467919305700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S0736467919305700"],"URL":"https:\/\/doi.org\/10.1016\/j.jemermed.2019.06.052","relation":{},"ISSN":["0736-4679"],"issn-type":[{"value":"0736-4679","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ibogaine Consumption With Seizure-Like Episodes, QTc-Prolongation, and Captured Cardiac Dysrhythmias","name":"articletitle","label":"Article Title"},{"value":"The Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jemermed.2019.06.052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}